Interleukin family member ST2 and mortality in acute dyspnoea

被引:49
作者
Socrates, T. [1 ]
deFilippi, C. [2 ]
Reichlin, T. [1 ]
Twerenbold, R. [1 ]
Breidhardt, T. [1 ]
Noveanu, M. [1 ]
Potocki, M. [1 ]
Reiter, M. [1 ]
Arenja, N. [1 ]
Heinisch, C. [1 ]
Meissner, J. [1 ]
Jaeger, C. [1 ]
Christenson, R. [2 ]
Mueller, C. [1 ]
机构
[1] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
基金
瑞士国家科学基金会;
关键词
acute decompensated heart failure; BNP; dyspnoea; NT-proBNP; ST2; CONGESTIVE-HEART-FAILURE; NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; SOLUBLE ST2; RISK STRATIFICATION; RECEPTOR; EXPRESSION; MANAGEMENT; BIOMARKER; ASSAY;
D O I
10.1111/j.1365-2796.2010.02263.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Socrates T, deFilippi C, Reichlin T, Twerenbold R, Breidhardt T, Noveanu M, Potocki M, Reiter M, Arenja N, Heinisch C, Meissner J, Jaeger C, Christenson R, Mueller C. (Department of Internal Medicine, University Hospital Basel, Basel, Switzerland; University of Maryland, School of Medicine, Baltimore, MD, USA). Interleukin family member ST2 and mortality in acute dyspnoea. J Intern Med 2010; 268: 493-500. Objectives. The study objective was to investigate the prognostic utility and patient-specific characteristics of ST2 (suppression of tumorigenicity 2), assessed with a novel sensitive assay. Background. Suppression of tumorigenicity 2 signalling has been shown to be associated with death in cardiac and pulmonary diseases. Design/Subjects. In an international multicentre cohort design, we prospectively enrolled 1091 patients presenting with acute dyspnoea to the emergency department (ED). ST2 was measured in a blinded fashion using a novel assay and compared to B-type natriuretic peptide (BNP) and NT-proBNP. The primary end-point was mortality within 30 days and 1 year. The prognostic value of ST2 was evaluated in comparison and in addition to BNP and NT-proBNP. Results. Suppression of tumorigenicity 2 concentrations was higher amongst decedents than among survivors (median 85 vs. 43 U mL-1, P < 0.001) and also higher in patients with impaired left ventricular ejection fraction (LVEF) when compared with preserved LVEF (P < 0.001). In receiver operator characteristics analysis, the area under the curve (AUC) for ST2, BNP and NT-proBNP to predict 30-day and 1-year mortality were 0.76, 0.63 and 0.71, and 0.72, 0.71 and 0.73, respectively. The combinations of ST2 with BNP or NT-proBNP improved prediction of mortality provided by BNP or NT-proBNP alone. After multivariable adjustment, ST2 values above the median (50 U mL-1) significantly predicted 1-year mortality (HR 2.3, P < 0.001). Conclusion. In patients presenting to the ED with acute dyspnoea, ST2 is a strong and independent predictor of 30-day and 1-year mortality and might improve risk stratification already provided by BNP or NT-proBNP.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 33 条
[21]   Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA centaur BNP assay [J].
Mueller, T ;
Gegenhuber, A ;
Poelz, W ;
Haltmayer, M .
CLINICAL CHEMISTRY, 2004, 50 (06) :1104-1106
[22]   Expression of ST2 in helper T lymphocytes of malignant pleural effusions [J].
Oshikawa, K ;
Yanagisawa, K ;
Ohno, S ;
Tominaga, S ;
Sugiyama, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :1005-1009
[23]   Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation [J].
Oshikawa, K ;
Kuroiwa, K ;
Tago, K ;
Iwahana, H ;
Yanagisawa, K ;
Ohno, S ;
Tominaga, SI ;
Sugiyama, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (02) :277-281
[24]   Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study [J].
Potocki, Mihael ;
Breidthardt, Tobias ;
Reichlin, Tobias ;
Morgenthaler, Nils G. ;
Bergmann, Andreas ;
Noveanu, Markus ;
Schaub, Nora ;
Uthoff, Heiko ;
Freidank, Heike ;
Buser, Lorenz ;
Bingisser, Roland ;
Christ, Michael ;
Mebazaa, Alexandre ;
Mueller, Christian .
CRITICAL CARE, 2009, 13 (04)
[25]   Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure [J].
Rehman, Shafiq U. ;
Mueller, Thomas ;
Januzzi, James L., Jr. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1458-1465
[26]   Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction [J].
Sabatine, Marc S. ;
Morrow, David A. ;
Higgins, Luke J. ;
MacGillivray, Catherine ;
Guo, Wei ;
Bode, Christophe ;
Rifai, Nader ;
Cannon, Christopher P. ;
Gerszten, Robert E. ;
Lee, Richard T. .
CIRCULATION, 2008, 117 (15) :1936-1944
[27]   IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [J].
Schmitz, J ;
Owyang, A ;
Oldham, E ;
Song, YL ;
Murphy, E ;
McClanahan, TK ;
Zurawski, G ;
Moshrefi, M ;
Qin, JZ ;
Li, XX ;
Gorman, DM ;
Bazan, JF ;
Kastelein, RA .
IMMUNITY, 2005, 23 (05) :479-490
[28]   Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction [J].
Shimpo, M ;
Morrow, DA ;
Weinberg, EO ;
Sabatine, MS ;
Murphy, SA ;
Antman, EM ;
Lee, RT .
CIRCULATION, 2004, 109 (18) :2186-2190
[29]   ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis [J].
Tajima, Shunji ;
Bando, Masashi ;
Ohno, Shoji ;
Sugiyama, Yukihiko ;
Oshikawa, Katsuhisa ;
Tominaga, Shin-ichi ;
Itoh, Kouichi ;
Takada, Toshinori ;
Suzuki, Eiichi ;
Gejyo, Fumitake .
EXPERIMENTAL LUNG RESEARCH, 2007, 33 (02) :81-97
[30]   Does this dyspneic patient in the emergency department have congestive heart failure? [J].
Wang, CS ;
FitzGerald, JM ;
Schulzer, M ;
Mak, E ;
Ayas, NT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (15) :1944-1956